The present invention relates to an heparanase-binding and heparanase-neutralizing monoclonal antibody (IgG-1 mAb A54), including its epitope (HBD-II) and mode of interaction with heparanase, pharmaceutical composition comprising same, and uses thereof e.g. for inhibiting or treating a disease or disorder associated with heparanase activity, including but not limited to cancer, inflammation, viral infection, diabetes and related complications. The present invention further provides combinatorial cancer therapies, comprising the heparanase-neutralizing mAb and an additional anti-cancer treatment such as chemotherapy or radiation.
- 출원번호 : 18895539
- 출원인 : Technion Research & Development Foundation Limited
- 특허번호 :
- IPC : C07K-016/40(2006.01);A61K-031/69(2006.01);A61K-031/7068(2006.01);A61K-039/00(2006.01);A61K-039/395(2006.01);A61P-035/00(2006.01);A61P-035/04(2006.01);